Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors.
Colville CA
,
Seatter MJ
,
Jess TJ
,
Gould GW
,
Thomas HM
.
???displayArticle.abstract???
We have expressed the human isoforms of the liver-type (GLUT2) and brain-type (GLUT3) facilitative glucose transporters in oocytes from Xenopus laevis via injection of in vitro transcribed mRNA. As reported previously [Gould, Thomas, Jess and Bell (1991) Biochemistry 30, 5139-5145], GLUT2 mediates the transport of fructose and galactose, and GLUT3 mediates the transport of galactose. We have examined the effects of D-glucose, D-fructose and maltose on deoxyglucose transport in oocytes expressing GLUT2, and D-glucose, D-galactose and maltose on deoxyglucose transport in oocytes expressing GLUT3, and show that each sugar is a competitive inhibitor of transport. Moreover, D-glucose and maltose competitively inhibit fructose transport by GLUT2 and galactose transport by GLUT3, indicating that the transport of the alternative substrates for these transporters is likely to be mediated by the same outward-facing sugar-binding site used by glucose. Cytochalasin B is a non-competitive inhibitor of glucose transport by the well-characterized GLUT1 isoform. We show here that cytochalasin B is also a non-competitive inhibitor of the transport of deoxyglucose and alternative substrates by GLUT2 and GLUT3 expressed in oocytes. Km and Ki values for each substrate and inhibitor are presented for each isoform, together with further analysis of the binding sites for alternative substrates for these transporter isoforms.
Appleman,
Kinetics of the purified glucose transporter. Direct measurement of the rates of interconversion of transporter conformers.
1989, Pubmed
Appleman,
Kinetics of the purified glucose transporter. Direct measurement of the rates of interconversion of transporter conformers.
1989,
Pubmed
Appleman,
Rapid kinetics of the glucose transporter from human erythrocytes. Detection and measurement of a half-turnover of the purified transporter.
1985,
Pubmed
Axelrod,
Unique cytochalasin B binding characteristics of the hepatic glucose carrier.
1983,
Pubmed
Barnett,
Evidence for two asymmetric conformational states in the human erythrocyte sugar-transport system.
1975,
Pubmed
Bell,
Molecular biology of mammalian glucose transporters.
1990,
Pubmed
Bloch,
Inhibition of glucose transport in the human erythrocyte by cytochalasin B.
1973,
Pubmed
Carruthers,
ATP regulation of the human red cell sugar transporter.
1986,
Pubmed
Craik,
Kinetics of 3-O-methyl-D-glucose transport in isolated rat hepatocytes.
1979,
Pubmed
Devés,
Cytochalasin B and the kinetics of inhibition of biological transport: a case of asymmetric binding to the glucose carrier.
1978,
Pubmed
Elliott,
Sugar transport across the hepatocyte plasma membrane.
1982,
Pubmed
Fukumoto,
Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein.
1988,
Pubmed
Gorga,
Changes in the intrinsic fluorescence of the human erythrocyte monosaccharide transporter upon ligand binding.
1982,
Pubmed
Gould,
Facilitative glucose transporters: an expanding family.
1990,
Pubmed
Gould,
Expression of the brain-type glucose transporter is restricted to brain and neuronal cells in mice.
1992,
Pubmed
Gould,
Expression of a functional glucose transporter in Xenopus oocytes.
1989,
Pubmed
,
Xenbase
Kayano,
Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6).
1990,
Pubmed
,
Xenbase
Kayano,
Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues.
1988,
Pubmed
Keller,
Functional expression of the human HepG2 and rat adipocyte glucose transporters in Xenopus oocytes. Comparison of kinetic parameters.
1989,
Pubmed
,
Xenbase
King,
Cytochalasin B interferes with conformational changes of the human erythrocyte glucose transporter induced by internal and external sugar binding.
1991,
Pubmed
Kleinzeller,
Transport and phosphorylation of 2-deoxy-D-galactase in renal cortical cells.
1976,
Pubmed
Krupka,
Inhibition of sugar transport in erythrocytes by fluorodinitrobenzene.
1971,
Pubmed
Lacko,
[Kinetics of glucose uptake in erythrocytes. Effect of trans-concentration].
1972,
Pubmed
Olefsky,
Mechanisms of the ability of insulin to activate the glucose-transport system in rat adipocytes.
1978,
Pubmed
Thomas,
Tissue-specific expression of facilitative glucose transporters: a rationale.
1992,
Pubmed
,
Xenbase
Thorens,
Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells.
1988,
Pubmed
Vera,
Functional expression of mammalian glucose transporters in Xenopus laevis oocytes: evidence for cell-dependent insulin sensitivity.
1989,
Pubmed
,
Xenbase
Walmsley,
The dynamics of the glucose transporter.
1988,
Pubmed
